About the Authors
- Zachary A. Klase
-
Affiliation Department of Biological Sciences, University of the Sciences, Philadelphia, Pennsylvania, United States of America
- Svetlana Khakhina
-
Affiliation Department of Biological Sciences, University of the Sciences, Philadelphia, Pennsylvania, United States of America
- Adriano De Bernardi Schneider
-
Affiliation Department of Bioinformatics and Genomics, University of North Carolina at Charlotte, Charlotte, North Carolina, United States of America
- Michael V. Callahan
-
Affiliations Department of Medicine, Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America, Zika Foundation, College Station, Texas, United States of America
- Jill Glasspool-Malone
-
Affiliations Atheric Pharmaceutical, Scottsville, Virginia, United States of America, Global Clinical Scholars Research Training Program, Harvard Medical School, Boston, Massachusetts, United States of America
- Robert Malone
-
* E-mail: RWMaloneMD@gmail.com
Affiliations Atheric Pharmaceutical, Scottsville, Virginia, United States of America, Global Clinical Scholars Research Training Program, Harvard Medical School, Boston, Massachusetts, United States of America
Competing Interests
I have read the journal's policy and the authors of this manuscript have the following competing interests: Drs. Robert Malone and Jill Glasspool-Malone are principal stockholders of Atheric Pharmaceutical, LLC. Robert Malone is the managing partner of Atheric Pharmaceutical. Dr. Michael Callahan is the Chief Medical Officer of the Zika Foundation.